Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Common Equity (2017 - 2026)

Updated

Crinetics Pharmaceuticals' Common Equity was $1.19 billion in Q2 2026, up 1.7% from $1.17 billion a year earlier but down 6.9% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Common Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Crinetics Pharmaceuticals came in at $992.08 million, down 25.1% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
  • In earlier years, Common Equity was $1.32 billion in FY2024 (+145.7%), $539.11 million in FY2023 (+70.4%), $316.33 million in FY2022 (-4.7%) and $331.94 million in FY2021 (+96.5%).
  • Quarterly Common Equity has moved between $193.59 million (Q3 2021) and $1.32 billion (Q4 2024) over five years.
  • Compared with a year earlier, Common Equity was higher in seven of the last eight quarters, with growth averaging 36.2%.
  • The best year-over-year quarter for Common Equity over five years was Q2 2024 (growth of 226.9%); the worst was Q2 2023 (a decline of 34.2%).
  • Per Business Quant data, CRNX's Common Equity in the three quarters before Q2 2026 was $1.28 billion (Q1 2026), $992.08 million (Q4 2025) and $1.07 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 1.19 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.19 Bn
Mar 31, 2026 1.28 Bn
Dec 31, 2025 992.08 Mn
Sep 30, 2025 1.07 Bn
Jun 30, 2025 1.17 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.32 Bn
Sep 30, 2024 832.98 Mn
Jun 30, 2024 830.76 Mn
Mar 31, 2024 874.93 Mn
Dec 31, 2023 539.11 Mn
Sep 30, 2023 547.75 Mn
Jun 30, 2023 254.12 Mn
Mar 31, 2023 280.33 Mn
Dec 31, 2022 316.33 Mn
Sep 30, 2022 351.37 Mn
Jun 30, 2022 386.17 Mn
Mar 31, 2022 303.04 Mn
Dec 31, 2021 331.94 Mn
Sep 30, 2021 193.59 Mn
API Access

Crinetics Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY